WuXi Biologics (Cayman) Balance Sheet Health
Financial Health criteria checks 5/6
WuXi Biologics (Cayman) has a total shareholder equity of CN¥39.0B and total debt of CN¥3.0B, which brings its debt-to-equity ratio to 7.7%. Its total assets and total liabilities are CN¥52.1B and CN¥13.1B respectively. WuXi Biologics (Cayman)'s EBIT is CN¥4.2B making its interest coverage ratio -234.5. It has cash and short-term investments of CN¥8.7B.
Key information
7.7%
Debt to equity ratio
CN¥3.01b
Debt
| Interest coverage ratio | -234.5x |
| Cash | CN¥8.69b |
| Equity | CN¥39.04b |
| Total liabilities | CN¥13.10b |
| Total assets | CN¥52.14b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 2269 N's short term assets (CN¥17.9B) exceed its short term liabilities (CN¥8.1B).
Long Term Liabilities: 2269 N's short term assets (CN¥17.9B) exceed its long term liabilities (CN¥5.0B).
Debt to Equity History and Analysis
Debt Level: 2269 N has more cash than its total debt.
Reducing Debt: 2269 N's debt to equity ratio has increased from 0% to 7.7% over the past 5 years.
Debt Coverage: 2269 N's debt is well covered by operating cash flow (184.1%).
Interest Coverage: 2269 N earns more interest than it pays, so coverage of interest payments is not a concern.